KYTHERA BIOPHARMACEUTICALS I's ticker is KYTH and the CUSIP is 501570105. A total of 92 filers reported holding KYTHERA BIOPHARMACEUTICALS I in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $4,164,000 | -15.6% | 55,538 | -15.2% | 0.00% | 0.0% |
| Q2 2015 | $4,931,000 | +55.4% | 65,474 | +3.4% | 0.00% | +100.0% |
| Q1 2015 | $3,174,000 | +1200.8% | 63,304 | +798.8% | 0.00% | – |
| Q4 2014 | $244,000 | -6.9% | 7,043 | -12.1% | 0.00% | – |
| Q3 2014 | $262,000 | -19.9% | 8,010 | -5.9% | 0.00% | – |
| Q2 2014 | $327,000 | -86.1% | 8,513 | -85.6% | 0.00% | -100.0% |
| Q1 2014 | $2,351,000 | +62.6% | 59,119 | +52.8% | 0.00% | 0.0% |
| Q4 2013 | $1,446,000 | +1406.2% | 38,698 | +1738.4% | 0.00% | – |
| Q3 2013 | $96,000 | – | 2,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 900,559 | $33,636,000 | 3.14% |
| Redmile Group, LLC | 557,761 | $20,777,000 | 2.56% |
| SENZAR ASSET MANAGEMENT, LLC | 79,000 | $2,951,000 | 2.41% |
| Aureus Asset Management, LLC | 134,465 | $5,022,000 | 1.36% |
| REGENTATLANTIC CAPITAL LLC | 193,454 | $7,226,000 | 0.70% |
| PFM Health Sciences, LP | 831,840 | $31,069,000 | 0.62% |
| EAM Investors, LLC | 55,201 | $2,056,000 | 0.37% |
| Dynamic Technology Lab Private Ltd | 5,560 | $207,000 | 0.34% |
| Polar Capital LLP | 350,000 | $13,038,000 | 0.31% |
| Old West Investment Management, LLC | 10,773 | $402,000 | 0.24% |